Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 9

Review

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

       
Total article views   HTML views PDF downloads Totals
8,445 Dovepress* 8,445+ 2,245 10,690
Totals 8,445 2,245 10,690
*Since 27 June 2019
Total mentioned Facebook Delicious Reddit Twitter Others
22 0 0 0 7 15

View citations on Google Scholar